Talcum Powder

In 1977, The Lancet—a highly prestigious, peer-reviewed medical journal—published an unsigned article that found “no reason to believe” using baby powder made with talc could cause an increased risk of cancer. For decades, the paper was used in court by talc manufacturers like Johnson & Johnson as evidence that their products were safe. Now, nearly […]

Last fall, nearly 60,000 talcum powder claims were put on-hold after Johnson & Johnson—for the third time—attempted to file for Chapter 11 bankruptcy with its subsidiary company. Though J&J tried to bribe lawsuit participants with an $8 billion settlement, the U.S. Department of Justice filed a motion to dismiss its bankruptcy attempt, leading to all

During an early December court hearing, U.S. Bankruptcy Judge Christopher Lopez determined that all ongoing claims filed against Johnson & Johnson for the talcum powder lawsuit would remain paused until March 2025. In September 2024, Johnson & Johnson made its third attempt at filing for Chapter 11 bankruptcy by using its subsidiary company, now named

The U.S. Trustee Program, which oversees bankruptcy cases as part of the U.S. Department of Justice, filed a motion in October 2024 to dismiss yet another attempt for Johnson & Johnson to settle its ongoing talcum powder lawsuits through bankruptcy court. One month before the motion to dismiss, J&J used its subsidiary company, now named

Johnson & Johnson’s appeal of a 2023 court decision to dismiss its subsidiary company’s second attempt at filing for bankruptcy has been officially denied. In July 2024, the U.S. Third Circuit Court of Appeals agreed with the dismissal of LTL Management’s Chapter 11 bankruptcy case, stating that it “does not discern financial distress at LTL.”

In June 2024, the International Agency for Research on Cancer (IARC) re-evaluated its findings on whether or not the mineral talc could cause cancer. In its new monograph, the IARC declared talc to be a Group 2A substance that is “probably carcinogenic to humans.” This new classification is a major shift from the IARC’s previous

In June 2024, former talcum powder users filed a new lawsuit in a federal court requesting that Johnson & Johnson compensate women who either developed ovarian cancer or are at-risk of developing ovarian cancer with damages and preventative monitoring care.  The proposed medical monitoring system would cover the cost of doctor’s visits, diagnostic tests, pelvic

Last month, the Journal of Clinical Oncology released a major study from the researchers at the National Institutes of Health (NIH) exploring the connection between genital use of talcum powder and developing ovarian cancer. The NIH used data from The Sister Study to support its findings, which observed the medical history of over 50,000 middle-aged

Five plaintiffs involved in the talcum powder lawsuit have filed a class action complaint seeking for a federal court to issue a temporary restraining order to block Johnson & Johnson from attempting to file for bankruptcy anywhere outside of New Jersey, its home state. According to the lawsuit, J&J “executed a scheme through a series

In a stunning, but not unexpected move, Johnson & Johnson has filed for Chapter 11 bankruptcy for a second time. Once again, this will halt the progress of over 60,000 pending talcum powder lawsuits. This development comes only about two months after the U.S. Third Circuit Court of Appeals rejected J&J’s 2021 attempt to file